Table 1.

Names, peptide sequences reported in the review and their applications.

Name	Sequence 1	Application	Ref
Anticancer Applications—Diagnostic
VEGF-P3(CYC)	I76TMQ79CG92IHQGQHPKIRMI80CE93MSF96 *	Inhibition angiogenesis	[38,39]
D(LPR)	D(Leu-Pro-Arg)	Inhibition retinal angiogenesis; Diagnostic	[41,42,43]
SP5	PRPSPKMGVSVS *	Drug delivery	[44,45]
uPAR88–92	SRSRY *	Maintaining chemotactic activity and triggers directed cell migration and angiogenesis	[46,47]
RI-3	Ac-D(Tyr- Arg-Aib-Arg)- NH2	Prevent extracellular invasion by tumor cells	[48]
D(RGD)	D(Asp-Gly-Arg)	Diagnostic	[49,50,51]
VS	SWFSRHRYSPFAVS *	Glioblastoma multiforme (GBM)	[52,53]
VAP	SNTRVAP *	Gliomas, glioma stem cells, vasculogenic mimicry and neovasculature	[54]
WSW	SYPGWSW *	Glioma cells and tumor neovasculature	[55]
BK	RPPGFSPFR *	Glioma cells	[56]
FP21	YTRDLVYGDPARPGIQGTGTF *	Ovarian cancer	[57,58,59]
T7	HAIYPRH *	Drug delivery	[60]
Applications in Immunology
TG19320	(rty)4K2KG	IgG binding	[61,62]
VSVp	RGYVYQGL *	antigen surface of hepatitis B virus	[63]
OVAp	SIINFEKL *	antigen surface of hepatitis B virus	[63]
PS1	HQLDPAFGANSTNPD *	antigen surface of hepatitis B virus	[63]
HAI	HAIYPRH *	Crossing BBB	[64]
THR	THRPPMWSPVWP *	Crossing BBB	[64]
InsB:9–23	HLVEALYLVCGERGG *	Analogue of diabetogenic islet peptide—prevents T-cell activation in humanized model mice	[65,66]
Application in Neurodegenerative Diseases
Amytrap	WKGEWTGR *	Blocking the oligomerization and aggregation of Aβ1–42	[67,68,69,70,71]
IAPP11–20	RLANFLVHSS *	Strong inhibitory effects on amylin aggregation in T2DM	[72]
β-syn36–45	GVLYVGSKT *	Reduction of amyloid fibril and oligomer formation	[73]
Application in Antimicrobial Antibiotics
RI1018	rrwirvavilrv	Preventing formation of Biofilm	[74]
RI-JK6	rivwvrirrwqv	Preventing formation of Biofilm	[74]
RI-73	lwGvwrrvidwlr	Damaging the bacterial membrane	[75]
BMAP-28	GGLRSLGRKILRAWKKYGPIIVPIIRIG *	Broad antimicrobial activities	[76]

¹ The sequences reported are those of the parent peptides * (L-residues), unless otherwise indicated, like reporting D residues as lower-case letters or adding a “D” before the sequence.